Emergent BioSolutions Inc.EBSNYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR+3.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+3.1%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 337.99% |
| 2024 | 113.88% |
| 2023 | -72.05% |
| 2022 | -255.98% |
| 2021 | -75.67% |
| 2020 | 290.70% |
| 2019 | 433.66% |
| 2018 | -119.76% |
| 2017 | 773.30% |
| 2016 | -6350.42% |